Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
What It Is Class: Synthetic FOXO4-interacting peptide analog Concept: Modeled to disrupt binding between the transcription factor FOXO4 and p53 in senescent cells, promoting p53 relocalization in experimental systems
Some researchers set two reminders, one an hour before (to take medication out of the fridge) and one at injection time
However, the current evidence base is largely preclinical, and no large-scale human clinical trials have confirmed its efficacy
In May, Novo Nordisk announced it had filed a new drug application submission with the US FDA for an oral version of its popular weight-loss drug Wegovy (semaglutide), hoping to get a decision by the end of 2025
Any form of cell death that involves the release of damage-associated molecular patterns and the expression of immune-stimulating molecules on the cell surface to elicit an immune response against the dying cells
